WELCOME
  • Home
    • About the Haplo SCD Consortium
  • Patients & Families
    • Disease Information >
      • Signs and Symptoms
      • Treatment Options
    • Parent-To-Child (Haplo) Transplant >
      • Haplo Transplant Overview
      • Benefits of Haploidentical Donors
      • Meet a Donor
      • Meet a Patient
      • Trial Eligibility
      • Transplant Facilities Near You >
        • Travel and Housing
    • Video Education
    • Patient Advocacy Groups
    • Resources & External Links
  • Healthcare Professionals
    • Trial Aims and Hypotheses
    • Trial Eligibility
    • Preparative Regimen
    • Clinical Sites
    • Core Services
  • News & Events
  • Contact Us

HaPLo SDC consortium Sites

  • New York Medical Center (NYMC): Lead Institution; Administrative, Biostatistical and Financial Cores, Clinical Site, Immunology Core, Radiation Core, Neurocognitive Core, Donor Chimerism Core, Pulmonary Function and Vascular Cores
  • Medical College of Wisconsin (MCW): Clinical Site, Cell Processing Core, and Immunology Core
  • Tufts Medical Center: Clinical Site, HRQL Core
  • Children's Hospital Los Angeles (CHLA): Donor Chimerism Core
  • Washington University: Neuro-imaging Core
  • University of California Los Angeles (UCLA): Clinical Site
  • University of Chicago: Clinical Site, Processing Core
  • Boston Children's Hospital (BCH): Long Term Effects/Survivorship Core
  • John Hopkins University (JHU): Endothelial Biomarker Core
  • Texas Children's Hospital (TCH): Hepatic Imaging Core
  • Patient Advocates: Patient and Family Support


Picture
    Return to About Consortium
                                                                       Jump to Program Structure
Haplo Sickle Cell Disease Consortium
Contact Us       About Us